Reduced Mitochondrial Oxidative Capacity and Increased Mitochondrial Uncoupling Impair Myocardial Energetics in Obesity
Top Cited Papers
- 25 October 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 112 (17), 2686-2695
- https://doi.org/10.1161/circulationaha.105.554360
Abstract
Background— Obesity is a risk factor for cardiovascular disease and is strongly associated with insulin resistance and type 2 diabetes. Recent studies in obese humans and animals demonstrated increased myocardial oxygen consumption (MV̇o2) and reduced cardiac efficiency (CE); however, the underlying mechanisms remain unclear. The present study was performed to determine whether mitochondrial dysfunction and uncoupling are responsible for reduced cardiac performance and efficiency in ob/ob mice. Methods and Results— Cardiac function, MV̇o2, mitochondrial respiration, and ATP synthesis were measured in 9-week-old ob/ob and control mouse hearts. Contractile function and MV̇o2 in glucose-perfused ob/ob hearts were similar to controls under basal conditions but were reduced under high workload. Perfusion of ob/ob hearts with glucose and palmitate increased MV̇o2 and reduced CE by 23% under basal conditions, and CE remained impaired at high workload. In glucose-perfused ob/ob hearts, mitochondrial state 3 respi...Keywords
This publication has 30 references indexed in Scilit:
- Impaired Cardiac Efficiency and Increased Fatty Acid Oxidation in Insulin-Resistant ob/ob Mouse HeartsDiabetes, 2004
- Alterations in left ventricular structure and function in young healthy obese womenJournal of the American College of Cardiology, 2004
- Treatment of type 2 diabeticdb/dbmice with a novel PPARγ agonist improves cardiac metabolism but not contractile functionAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Cardiac Lipid Accumulation Associated with Diastolic Dysfunction in Obese MiceEndocrinology, 2003
- Myocardial triglycerides and systolic function in humans: In vivo evaluation by localized proton spectroscopy and cardiac imagingMagnetic Resonance in Medicine, 2003
- Echocardiographic assessment of cardiac function in diabeticdb/db and transgenic db/db-hGLUT4 miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2002
- Cardiac function and metabolism in Type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-α activatorAmerican Journal of Physiology-Heart and Circulatory Physiology, 2002
- Lipotoxic DiseasesAnnual Review of Medicine, 2002
- The Continuing Epidemics of Obesity and Diabetes in the United StatesJAMA, 2001
- Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) miceAmerican Journal of Physiology-Endocrinology and Metabolism, 2000